Home Applications 021544 Application 021544
Type NDA
Sponsor TEVA BRANDED PHARM Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 SEASONALE ETHINYL ESTRADIOL; LEVONORGESTREL TABLET;ORAL 0.03MG;0.15MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021544-001 SEASONALE ETHINYL ESTRADIOL; LEVONORGESTREL 0.03MG;0.15MG TABLET / ORAL AB RLD, RS 2003-09-05
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N021544-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N021544-001 SEASONALE 0.03MG;0.15MG TABLET / ORAL AB RLD, RS 2003-09-05 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N021544-001 SEASONALE 0.03MG;0.15MG TABLET / ORAL AB RLD, RS 2003-09-05 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N021544-001 SEASONALE 0.03MG;0.15MG TABLET / ORAL AB RLD, RS 2003-09-05 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N021544-001 SEASONALE 0.03MG;0.15MG TABLET / ORAL AB RLD, RS 2003-09-05 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 44 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 6 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0555-9123 Jolessa Levonorgestrel / Ethinyl Estradiol Teva Pharmaceuticals USA, Inc. NDA AUTHORIZED GENERIC Current 0555-9123 Jolessa Levonorgestrel / Ethinyl Estradiol Teva Pharmaceuticals USA, Inc. NDA AUTHORIZED GENERIC Current 0555-9123 Jolessa Levonorgestrel / Ethinyl Estradiol Teva Pharmaceuticals USA, Inc. NDA AUTHORIZED GENERIC Current 0555-9123 Jolessa Levonorgestrel / Ethinyl Estradiol Teva Pharmaceuticals USA, Inc. NDA AUTHORIZED GENERIC Current 0555-9123 Jolessa Levonorgestrel / Ethinyl Estradiol Teva Pharmaceuticals USA, Inc. NDA AUTHORIZED GENERIC Current 53002-1779 Jolessa Levonorgestrel / Ethinyl Estradiol RPK Pharmaceuticals, Inc. NDA AUTHORIZED GENERIC Current